CO4940417A1 - DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA - Google Patents

DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA

Info

Publication number
CO4940417A1
CO4940417A1 CO98015204A CO98015204A CO4940417A1 CO 4940417 A1 CO4940417 A1 CO 4940417A1 CO 98015204 A CO98015204 A CO 98015204A CO 98015204 A CO98015204 A CO 98015204A CO 4940417 A1 CO4940417 A1 CO 4940417A1
Authority
CO
Colombia
Prior art keywords
dihydrophide
piridine
therapeutics
derivatives
preparation
Prior art date
Application number
CO98015204A
Other languages
English (en)
Inventor
Lochead Alistair
Jegham Samir
Frederic Galli
Thierry Gallet
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of CO4940417A1 publication Critical patent/CO4940417A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compuesto, en forma de isómero óptico puro o de mezcla detales isómeros, que responde a la fórmulageneral (I)en la cualR1 representa un átomo de hidrógeno, un grupo (C1 -C6 ) alquilo o un grupo fenil (C1 -C4 ) alquilo,R2 representa un átomo de hidrógeno o un grupo (C1 -C6 )alquilo,yR3 , R4 , y R5 representan cada uno, independientemente uno de otro, un átomo de hidrógeno o de halógeno o un grupo trifluorometilo, ciano, hidroxi, (C1 -C6 )alquilo o (C1 -C6 ) alcoxi, en estado de base o de sal de adición a un ácido.
CO98015204A 1997-03-20 1998-03-18 DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA CO4940417A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9703395A FR2761072B1 (fr) 1997-03-20 1997-03-20 Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
CO4940417A1 true CO4940417A1 (es) 2000-07-24

Family

ID=9505006

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98015204A CO4940417A1 (es) 1997-03-20 1998-03-18 DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA

Country Status (22)

Country Link
US (1) US6143761A (es)
EP (1) EP0971929A1 (es)
JP (1) JP2001518099A (es)
KR (1) KR20000076282A (es)
CN (1) CN1251105A (es)
AR (1) AR012097A1 (es)
AU (1) AU6924298A (es)
BG (1) BG103684A (es)
BR (1) BR9808346A (es)
CA (1) CA2282320A1 (es)
CO (1) CO4940417A1 (es)
EE (1) EE9900414A (es)
FR (1) FR2761072B1 (es)
HU (1) HUP0002335A3 (es)
IL (1) IL131254A0 (es)
NO (1) NO994527L (es)
NZ (1) NZ337566A (es)
PL (1) PL335759A1 (es)
SK (1) SK127699A3 (es)
TR (1) TR199902115T2 (es)
WO (1) WO1998042713A1 (es)
ZA (1) ZA982365B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790474B1 (fr) * 1999-03-05 2001-04-06 Synthelabo Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds
JP2005104838A (ja) * 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
GB2448224B (en) 2007-04-02 2010-09-01 Parkinson S Inst Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4176147B2 (ja) * 1995-07-28 2008-11-05 アボツト・ラボラトリーズ 化学的シナプス伝達の制御に有用なフロピリジン、チエノピリジン、ピロロピリジンおよび関連するピリミジン、ピリダジンおよびトリアジン化合物

Also Published As

Publication number Publication date
HUP0002335A2 (hu) 2001-05-28
HUP0002335A3 (en) 2002-07-29
BR9808346A (pt) 2000-05-23
AR012097A1 (es) 2000-09-27
BG103684A (en) 2000-06-30
JP2001518099A (ja) 2001-10-09
CA2282320A1 (en) 1998-10-01
US6143761A (en) 2000-11-07
NO994527D0 (no) 1999-09-17
SK127699A3 (en) 2000-05-16
FR2761072A1 (fr) 1998-09-25
EE9900414A (et) 2000-04-17
NO994527L (no) 1999-11-18
AU6924298A (en) 1998-10-20
PL335759A1 (en) 2000-05-22
TR199902115T2 (xx) 2000-01-21
FR2761072B1 (fr) 1999-04-23
WO1998042713A1 (fr) 1998-10-01
CN1251105A (zh) 2000-04-19
ZA982365B (en) 1998-09-23
NZ337566A (en) 2000-09-29
EP0971929A1 (fr) 2000-01-19
KR20000076282A (ko) 2000-12-26
IL131254A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
AR021534A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion en terapeutica
CO5180557A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas y sus composiciones farmaceuticas .
AR021533A1 (es) Derivados de 2,5-diazabiciclo[2.2.1]heptano, su preparacion y su aplicacion en terapeutica
CO4770975A1 (es) Derivados de quinazolina sustituidos
ES2193990T3 (es) Derivados de purina.
CO5700820A2 (es) Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
CO4770968A1 (es) Derivados de 5-fenil-3-(piperidin-4-il)-1,3,4-oxidiazol- 2(3h)-ona, su preparacion y su aplicacion en terapeutica
ES2191611T3 (es) Compuesto bajo forma de isomero geometrico u optico puro o de mezcla de tales isomeros.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES2054309T3 (es) Compuestos de urea sustituida y su preparacion y uso.
HUP0302157A2 (hu) 4-(2-Fenil-tiazol-5-il)-1,4-diazabiciklo[3.2.2]nonán-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
AR027296A1 (es) Derivados de 4-heteroaril-1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion terapeutica
CO4700298A1 (es) Derivados de 3-fenilisoquinoleina-1 (2h)-ona, su preparacion y su aplicacion en la terapeutica
CO4940417A1 (es) DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
AR028647A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano benzoxazol, benzotiazol y bencimidazol, su preparacion y su aplicacion en terapéutica
HRP20000508B1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
ES2037257T3 (es) Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas.
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP1314730A4 (en) REAGENT FOR DETERMINING SINGLET OXYGEN
CO4890850A1 (es) Derivados de 6-pirrolidin-2-ilpiridinas, su reparacion y preparacion en terapeutica.
AU9025601A (en) Cephem compounds and esbl-detecting reagents containing the same
CO4750656A1 (es) Derivados de 5-aril-3-(8-azabiciclo[3.2.1]oct-3-il)-1,3,4- oxadiazol-2 (3h)-ona, su preparacion y medicamentos que lo contienen
CO4900067A1 (es) Derivados de 3-[(1,2,3,4-tetrahidroisoquionolein-2-il)me- til]-8-azabiciclo [3.2.1.]octano, su preparacion y su apli- cacion en terapeutica
CO4700285A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion y su aplciacion en la terapeutica